A CLEAR VIEW: VISUALIZING THE IV FLUID PATH AS AN EMERGINGCONCEPT IN INFECTION CONTROL, BY MARILYN HANCHETT, RN, PHD, PAGE 36.
1. Hankins J, et al, editors, Infusion Therapy in ClinicalPractice. Philadelphia:W. B. Saunders Company, 2001, page 1.
2. Frequently Asked Questions, National Home InfusionAssociation web site (www.nhianet.org), 2003.
3. The Centers for Disease Control. Guidelines for thePrevention of Intravascular Catheter-Related Infections, MMWR Recommendationsand Reports, August 9, 2002/ 51(RR10) page. 3.
4. Crnich DJ, Maki DG. The promise of novel technology for the prevention of intravascular devicerelated bloodstream infection. II. Long-term devices. Clin Infect Dis. 2002 May 15; 34 (10):1362-8
5. Kluger DM, Maki DG. The relative risk of intravascular device related bloodstream infections in adults (abstract). In Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA: American Society for Microbiology, 1999; 27: 520-532.
Robust infectious disease surveillance, including rapid subtyping of influenza A, is essential for early detection, containment, and public health reporting of novel viral threats.